4//SEC Filing
WEISS MICHAEL S 4
Accession 0001104659-23-119186
CIK 0001429260other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 5:46 PM ET
Size
7.7 KB
Accession
0001104659-23-119186
Insider Transaction Report
Form 4
WEISS MICHAEL S
Director
Transactions
- Purchase
COMMON STOCK, PAR VALUE $0.001
2023-11-14$1.70/sh+147,058$249,999→ 1,130,520 total - Purchase
Warrants to purchase Common Stock
2023-11-14+147,058→ 147,058 totalExercise: $1.70From: 2023-11-14Exp: 2028-11-14→ Common Stock (147,058 underlying)
Footnotes (2)
- [F1]Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split.
- [F2]The shares of common stock and warrants to purchase common stock reflect on this Form 4 were purchased as units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock, at a price per unit of $1.70.
Documents
Issuer
Fortress Biotech, Inc.
CIK 0001429260
Entity typeother
Related Parties
1- filerCIK 0001038977
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 5:46 PM ET
- Size
- 7.7 KB